EZCORP (EZPW) Rallies On Expansion Hopes, Is It Still 10% Undervalued?

EZCORP, Inc. Class A

EZCORP, Inc. Class A

EZPW

0.00

EZCORP (EZPW) has drawn fresh attention as investors reassess the pawn-focused lender’s US$2.19b market value, supported by annual revenue of US$1,476.69m and net income of US$146.61m across its U.S. and Latin America operations.

Over the past year, EZCORP’s share price return has been strong, with a year to date gain of 77.42% and a recent 90 day share price return of 28.67%. The 1 year total shareholder return of 153.49% points to building momentum supported by dividends or other distributions.

If you are looking beyond EZCORP for other financials with potential, this could be a good time to broaden your research through the 20 top founder-led companies

EZCORP’s strong share price run and current 11% gap to the US$39.60 analyst target pull in opposite directions, so the next step is to weigh that discount against the market’s caution on valuation.

Most Popular Narrative: 10.1% Undervalued

EZCORP's most followed narrative places fair value at $39.60, above the last close of $35.59. This puts the current analyst thinking under the spotlight.

Ongoing and accelerated store footprint expansion, particularly in large underserved markets across Latin America (e.g., recent acquisitions in Mexico and new de novo stores in Guatemala and El Salvador), diversifies geographic risk and significantly increases addressable market size, positioning the company for outsized topline and EBITDA growth.

Want to see what sits behind that growth story for EZCORP? The narrative leans on steady revenue expansion, firmer margins, and a richer earnings multiple. The exact mix of those assumptions may surprise you.

Result: Fair Value of $39.60 (UNDERVALUED)

However, the EZCORP narrative still leans on jewelry and gold price exposure, as well as on-store expansion, where weaker trends or costly build outs could quickly challenge those assumptions.

Another View on EZCORP’s Valuation

The analyst narrative suggests EZCORP is about 10.1% undervalued at $35.59 versus a $39.60 fair value, but the P/E picture is more cautious. EZCORP trades at 14.9x earnings, compared with 8.8x for the US Consumer Finance industry, a 9x peer average, and a 13.6x fair ratio. That richer multiple can mean investors have less margin for error if expectations change, so how comfortable are you with paying up for this growth story?

To unpack what those P/E gaps might mean for future valuation risk or opportunity, it is worth walking through the full earnings based comparison in our breakdown, including the fair ratio the market could move toward over time, in the See what the numbers say about this price — find out in our valuation breakdown.

NasdaqGS:EZPW P/E Ratio as at Jul 2026
NasdaqGS:EZPW P/E Ratio as at Jul 2026

Next Steps

With mixed signals around EZCORP’s valuation and outlook, this is a moment to move quickly, review the underlying data yourself, and decide where you stand on its balance of concerns and potential. To see that mix laid out clearly, check the 3 key rewards and 1 important warning sign.

Looking for more investment ideas beyond EZCORP?

If EZCORP has sharpened your focus, do not stop here. Fresh ideas from different corners of the market could help round out your next move.

  • Target potential mispricings by checking out companies flagged in the 44 high quality undervalued stocks.
  • Strengthen your income stream by reviewing businesses highlighted in the 7 dividend fortresses.
  • Prioritize resilience by searching through the 73 resilient stocks with low risk scores.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.